J. Biol. Chem. 1992, 267, 339-346
215 KOSTNER G., GRILLHOFER H.
Lipoprotein(a) mediates high affinity low density
lipoprotein association to receptor negative fibroblasts.
J. Biol. Chem. 1991, 266, 21287-21292
216 CUSHING G., GAUBATZ J., NAVA M., BURDICK B., BACAN T.
et al
Quantification and localization of apolipoprotein(a) and
B in coronary artery bypass vein grafts resected at re-operation.
Arteriosclerosis 1989, 9, 593-603
217 RATH M., NIENDORF A., REBLIN T., DIETEL
M., KREBBER H., BEISIEGEL U.
Detection and quantification of lipoprotein(a) in the
arterial wall of 107 coronary bypass patients. Arteriosclerosis 1989, 9,
579-595
216 YANAGI H., NAKAGAWA A., KIKUCHI S., TANAKA T.,
TSUCHIYA S. et al
Frequent occurrence of familial aggregation of high
lipoprotein(a) levels with small apolipoprotein(a) isoforms.
Hum. Genet. 1993, 92, 545-548
PUCKEY L.H., LAWN R.M., KNIGHT B.L.
Polymorphisms in the apolipoprotein (a) gene and their
relationship to allele size and plasma lipoprotein(a)
concentration.
Hum. Molec. Genet. 1997, 6, 1099-1107
220 KNIGHT B.L., PEROMBELON Y.F., SOUTAR A.K., WADE D.P.,
SEED M. Catabolism of lipoprotein(a) in familial hypercholesterolemic
subjects.
Atherosclerosis 1991, 87, 227-237
221 WIKLUND O., ANGELIN B., OLOFSSON S., ERIKSSON M.,
FAGER G. et al. Apolipoprotein(a) and ischaemic heart disease in familial
hypercholesterolemia. Lancet 1990, 335, 1360-1363
222 MBEWU A., BHATNAGAR D., DURRINGTON P., HUNT L.,
ISHOLA M.
Semi lipoprotein(a) in patients heterozygous for familial
hypercholesterolemia, their relatives, and unrelated control
populations.
Arterioscler. Thromb. 1991, 11, 940-946
223 GHISELLI G., GADDI A., BAROZZI G., CIARROCCHI A.,
DESCOVICH G.
Plasma lipoprotein(a) concentration in familial
hypercholesterolemic patients without coronary artery disease.
Metabolism 1992, 41, 833-838
224 KNIGHT B.
Lp(a) catabolism in hypercholesterolaemic individuals.
Chem. Phys. Lipid 1994, 67/68, 233-239
Thèse Docteur Pharmacie La lipoprotéine Lp(a) :
son intérêt dans l'interprétation du bilan lipidique Dr
GUIMONT MC 257/271 Lipides, Lipoprotéine (a),
Hyperlipoprotéinémie, Athérosclérose, Lipids,
Lipoprotein, Lpa, Hyperlipoproteinemia, Atherosclerosis
225 DE KNIJFF P., KAPTEIN A., BOOMSA D., PRINCEN H.,
FRANTS R. et al. Apolipoprotein E polymorphism affects plasma levels of
lipoprotein(a).
Atheroscler. 1991, 90, 169-174
226 HORITA K., ETO M., SAITO M., NAKATA H., IWASHIMA Y.
et al. Effects of apolipoprotein E polymorphism on plasma lipoprotein(a)
levels. Artery 1993, 20, 324-336
227 RITTER M.M., GEWITSCH J., RICHTER W.O., GEISS H.C.,
WILDNER M.W. et al. Apolipoprotein E polymorphism has no effect on plasma
levels of lipoprotein(a). Atheroscl. 1997, 131, 243-248
228 SANDHOLZER C., FEUSSNER G., BRUNZELL J., UTERMANN
G.
Distribution of apolipoprotein(a) in the plasma from
patients with lipoprotein lipase deficiency and type Ill hyperlipoproteinemia.
No evidence for a triglyceride-rich precursor of lipoprotein(a).
| 
